The aim of this study is to explore the clinicopathologic features of MYD88-mutated CLL/SLL and to determine whether L265P vs. non-L265P MYD88 mutations show different characteristics. This evidence concerns the gene MYD88 and B-cell chronic lymphocytic leukemia.